That sucking sound? Layoffs draining brains from pharma

Tens of thousands of pharma layoffs have left highly qualified employees--from scientists to marketing specialists to finance whizzes--without jobs. "I think we're losing so much expertise," one pharma recruiter said. Report

Suggested Articles

A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Zantac and some OTC antacids.

Roche is steamrolling with Ocrevus, and to maintain that lead, its touting long-term data that show the earlier it’s given, the better patients do.

New data shows a significant reduction in relapse rates in patients taking Novartis' repurposed cancer drug ofatumumab.